Novel therapeutic strategies for reducing arterial stiffness
Open Access
- 1 August 2006
- journal article
- editorial
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (7) , 881-883
- https://doi.org/10.1038/sj.bjp.0706805
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Improved cardiovascular function with aminoguanidine in DOCA‐salt hypertensive ratsBritish Journal of Pharmacology, 2006
- Aminoguanidine and Aortic Wall Mechanics, Structure, and Composition in Aged RatsHypertension, 2001
- Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink BreakerCirculation, 2001
- Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive PatientsHypertension, 2001
- Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US HypertensivesHypertension, 2001
- Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal FailureCirculation, 2001
- A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeysProceedings of the National Academy of Sciences, 2001
- Arterial stiffness, hypertension and diabetes mellitusJournal of Human Hypertension, 2000
- An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffnessProceedings of the National Academy of Sciences, 2000
- Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trialsThe Lancet, 2000